Dimethylamine

Dimethylamine

SCHEMBL7146086

CNC.NS(=O)(=O)c1cccc(S(=O)(=O)O)c1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.65
CA1 P00915 12/20 0.65
TSHR P16473 2/20 0.55
ALDH1A1 P00352 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
CA12 O43570 9/20 0.52
CA9 Q16790 9/20 0.52
CA14 Q9ULX7 3/20 0.52
CA4 P22748 2/20 0.52
NOS1 P29475 1/20 0.50
MAPT P10636 1/20 0.47
POLB P06746 1/20 0.46
CA5A P35218 2/20 0.45
CA3 P07451 1/20 0.45
CA6 P23280 1/20 0.45
CA7 P43166 1/20 0.45
PLA2G7 Q13093 1/20 0.45
CA13 Q8N1Q1 1/20 0.45
CA5B Q9Y2D0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylamine SCHEMBL7142670 0.92 CA2 (0.71) CA2CA1TSHRALDH1A1HSD17B10
SCHEMBL1498176 0.92 CA2 (0.77) CA2CA1TSHRALDH1A1HSD17B10
Tert-Butylamine SCHEMBL7141555 0.87 CA2 (0.63) CA2CA1TSHRALDH1A1HSD17B10
Dimethylamine SCHEMBL8501482 0.86 KDM4E (0.60) CA2CA1TSHRALDH1A1HSD17B10
SCHEMBL7144247 0.81 CA2 (0.61) CA2CA1TSHRALDH1A1HSD17B10
Hydrazine SCHEMBL28622261 0.81 ALDH1A1 (0.71) CA2CA1TSHRALDH1A1HSD17B10
SCHEMBL2398133 0.81 CA2 (1.00) CA2CA1CA12CA9CA14
SCHEMBL1563586 0.81 ALDH1A1 (0.70) CA2CA1TSHRALDH1A1HSD17B10
SCHEMBL151444 0.81 ALDH1A1 (0.70) CA2CA1TSHRALDH1A1HSD17B10
SCHEMBL7144393 0.79 CA2 (0.57) CA2CA1TSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
EP-1214087-A1 COMBINATION TREATMENT WITH IL-1RA AND COMPOUNDS THAT INHIBIT IL-1 PROCESSING AND RELEASE Pfizer Products Inc. (US) 2002-06-19 EP disclosed
WO-2001019390-A1 COMBINATION TREATMENT WITH IL-1RA AND DIARYL SULPHONYL UREA COMPOUNDS PFIZER PRODUCTS INC. (US) 2001-03-22 WO disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed